Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 3, 2000, Pages 837-844

  Gekle, Michael ^a   Schwerdt, Gerald ^a   Freudinger, Ruth ^a   Mildenberger, Sigrid ^a   Wilflingseder, Doris ^b   Pollack, Verena ^b   Dander, Martina ^b   Schramek, Herbert ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DNA FRAGMENT; OCHRATOXIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL SPECIFICITY; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; MYCOTOXINS; OCHRATOXINS; PHOSPHORYLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034045754     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Blumer KJ and Johnson GL (1994) Diversity in function and regulation of MAP kinase pathways. Trends Biochem Sci 19:236-240.
2. Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F and Gulbins E (1997) Fas-or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 272: 22173-22181.
3. 2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem 272:10110-10116.
4. Davies RJ (1994) MAPKs: New JNK expands the group. Trends Biochem Sci 19: 470-473.
5. Delacruz L and Bach PH (1990) The role of ochratoxin A metabolism and biochemistry in animal and human nephrotoxicity. J Biopharm Sci 1:277-304.
6. Derijard B, Hibi M, Wu IH, Barret T, Su B, Deng T, Karin M and Davis RJ (1994) JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
7. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL and Davis RJ (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science (Wash DC) 277:693-696.
8. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A and Nagata S (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (Lond) 391:43-50.
9. Gekle M, Sauvant C, Schwerdt G and Silbernagl S (1998) Tubulotoxic mechanisms of ochratoxin A. Kidney Blood Press Res 21:277-279.
10. Gekle M and Silbernagl S (1996) Renal toxicodynamics of ochratoxin A: A pathophysiological approach. Kidney Blood Press Res 19:225-235.
11. Gekle M, Wünsch S, Oberleithner H and Silbernagl S (1994) Characterization of two MDCK-cell subtypes as a model system to study principal and intercalated cell properties. Pflügers Arch 428:157-162.
12. Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E and Sanchez I (1997) Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 94:3302-3307.
13. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B and Davis RJ (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. Embo J 15:2760-2770.
14. Hibi M, Lin A, Smeal T, Minden A and Karin M (1993) Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7:2135-2148.
15. Imura O, Vrtovsnik F, Terzi F and Friedlander G (1997) HMG-CoA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture. Kidney Int 52:962-972.
16. Ip YT and Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10:205-219.
17. Kroermer G, Petit P, Zamzami N, Vayssière J-L and Mignotte B (1995) The biochemistry of programmed cell death. FASEB J 9:1277-1287.
18. Kuiper-Goodman T and Scott PM (1989) Risk assessment of the mycotoxin Ochratoxin A. Biomed Environ Sci 2:179-248.
19. Lewis TS, Shapiro PS and Ahn NG (1998) Signal transduction through MAP kinase cascades. Adv Corner Res 74:49-139.
20. Montesano R, Soriano JV, Hosseini G, Pepper MS and Schramek H (1999) Constitutively active mutant of the mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells. Cell Growth Diff 10:317-332.
21. Natoli G, Costanzo A, lanni A, Templeton DJ, Woodgett JR, Balsano C and Levrero M (1997) Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science (Wash DC) 275:200-203.
22. Nishina H, Fischer KD, Radvanyl L, Shahinian A, Hakem R, Ruble EA, Bernstein A, Mak TW, Woodgett JR and Penninger JM (1997) Stress-signaling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature (Lond) 385:350-353.
23. Patel T, Gores GJ and Kaufmann SH (1996) The role of proteases during apoptosis. FASEB J 10:587-597.
24. Quarrie LH, Addey CVP and Wilde CJ (1995) Apoptosis in lactating and involuting mouse mammary tissue demonstrated by nick-end DNA labelling. Cell Tissue Res 281:413-419.
25. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM and Zon LI (1994) Role of SAPK/ERK kinase-1 in stress-activated pathway regulating transcription factor c-Jun. Nature (Lond) 372:794-798.
26. Sandau K, Pfeilschifter J and Brüne B (1997) Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int 52:378-386.
27. Schramek H, Feifel E, Healy E and Pollack V (1997a) Constitutively active mutant of the mitogen-activated protein kinase kinase MEK1 induces epithelial dedifferentiation and growth inhibition in Madin-Darby canine kidney-C7 cells. J Biol Chem 272:11426-11433.
28. Schramek H, Schumacher M, Wilflingseder D, Oberleithner H and Pfaller W (1997b) Differential expression and activation of MAP kinases in dedifferentiated MDCK-focus cells. Am J Physiol 272:C383-C391.
29. Schramek H, Wilflingseder D, Pollack V, Freudinger R, Mildenberger S and Gekle M (1997c) Ochratoxin A-induced stimulation of extracellular signal-regulated kinases 1/2 is associated with Madin-Darby canine kidney-C7 cell dedifferentiation. J Pharmacol Exp Ther 283:1460-1468.
30. Schwerdt G, Gekle M, Freudinger R, Mildenberger S and Silbernagl S (1997) Apical-to-basolateral transepithelial transport of ochratoxin A by two subtypes of Madin-Darby canine kidney cells. Biochim Biophys Acta 1324:191-199.
31. Seegers JC, Böhmer LH, Kruger MC, Lottering M-L and De Kock M (1994) A comparative study of ochratoxin A-induced apoptosis in hamster kidney and HeLa cells. Toxicol Appl Pharmacol 129:1-11.
32. Seger R and Krebs EG (1995) The MAPK signaling cascade. FASEB J 9:726-735.
33. 2-terminal kinase-mediated activation of interleukin-1β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J Biol Chem 4631:-4636.
34. Simon P (1996) Ochratoxin and kidney disease in the human. J Toxicol 15:239-249.
35. Teng DH, Perry III WL, Hogan JK, Baumgard M, Bell R, Davis T, Frank D, Frye C, Hattier T, Hu R, Jammulapati S, Janecki T, Laevitt A, Mitvhell JT, Pero P, Sexton D, Schroeder M, Su P-H, Swedlund B, Kyriakis JM, Avruch J and Bartel P (1997) Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res 57:4177-4182.
36. Whitmarsh AJ and Davis RJ (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607.
37. Wünsch S, Gekle M, Kersting U, Schuricht B and Oberleithner H (1995) Phenotypically and karyotypically distinct Madin-Darby canine kidney cell clones respond differently to alkaline stress. J Cell Physiol 164:164-171.
38. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Wash DC) 270:1326-1331.